Cardiovascular consequences of cooling in critical care by Steendijk, Paul
In a previous issue of Critical Care, Filseth and colleagues 
[1] describe the cardiovascular eﬀ  ects of surface cooling 
towards severe hypothermia (25°C) and subsequent 
surface re-warming in an anesthetized, closed-chest pig 
model, focusing particularly on post-hypothermic ventri-
cular function.
Hypothermia may improve outcome after an ischemic 
event. Remarkable, anecdotal examples of this pheno-
menon are known from skiing accidents, winter warfare 
and other cold, human pastimes. In medicine, intentional 
use of controlled hypothermia has a long history. 
Presumably, the most widely used and accepted thera-
peutic applications are cooling to enable procedures with 
prolonged ischemia, such as open heart surgery, organ 
preservation and transplantation. In planned surgery, 
hypothermia is typically induced as a protective strategy 
before the start of ischemia. Currently, however, the 
eﬃ     cacy of hypothermia as an emergency treatment 
during ongoing ischemia or reperfusion in cases such as 
stroke, myocardial infarction, and cardiac arrest is 
receiving much attention. Randomized clinical trials have 
demonstrated that treatment with moderate hypothermia 
improves survival and neurological outcome in un-
conscious patients after resuscitation from out-of-
hospital cardiac arrest [2,3]. As a result, recent American 
and European guidelines recommend the induction of 
therapeutic hypothermia for comatose cardiac arrest 
survivors [4,5]. Research has importantly focused on 
hypothermia as a neuroprotective strategy and a wide 
range of pathways that might be involved in the beneﬁ  cial 
eﬀ  ects of cooling has been described. Th   e basic theory is 
that hypothermia slows down cellular metabolism and 
oxygen demand and thereby reduces the harmful acute 
and delayed eﬀ  ects of oxygen deprivation. Hypothermia 
attenuates ischemia-induced free radical production, and 
abnormalities in cellular calcium handling and pH 
balance [6]. Furthermore, hypothermia may target more 
delayed cell death processes by aﬀ  ecting inﬂ  ammatory 
signaling and apoptotic pathways [7]. In principle, these 
protective mechanisms apply not only to the brain but 
also to the heart (and other organs, for that matter). 
However, in contrast to rather convincing animal data 
[8], clinical studies aiming to determine whether hypo-
thermia limited infarct size in patients with ST segment 
elevation myocardial infarction (STEMI) under  going 
percutaneous revascularization [9] or in survivors of 
cardiac arrest [10] did not clearly establish such an eﬀ  ect.
In addition to the pursued protective eﬀ  ects,  hypo-
thermia induces important physiological changes, or side 
eﬀ  ects, in almost every organ system. Th   ese changes partly 
result from physiological thermoregulatory reﬂ  exes aimed 
at decreasing heat loss and restoring normal temperature, 
such as sympathetic activation, cutaneous vasocon-
striction, and shivering. More generally, enzyme kinetics 
are temperature-dependent and thus, in principle, all 
enzyme-mediated reactions, including drug metabolism, 
are aﬀ   ected by hypothermia. Th   e direct eﬀ  ect  of 
temperature per se on myocardial function has been the 
subject of various previous studies. Basic in vitro studies 
in muscle strips from healthy myocardium have shown 
substantially increased contractility (measured as 
Abstract
This commentary discusses a paper by Filseth 
and colleagues in a previous issue of Critical Care. 
The authors describe the cardiovascular eff  ects of 
induced hypothermia, focusing particularly on post-
hypothermic ventricular function. The fi  ndings indicate 
that the treatment resulted in reduced systolic but 
unchanged diastolic left ventricular function with 
compensatory eff  ects on heart rate and systemic 
vascular resistance. The novel aspects of this study 
are the registration of ventricular function using 
sophisticated, load-independent indices in a clinically 
relevant, large animal model during the entire cooling 
and re-warming trajectory of hypothermia therapy.
© 2010 BioMed Central Ltd
Cardiovascular consequences of cooling in critical 
care
Paul Steendijk*
See related research by Filseth et al., http://ccforum.com/content/14/6/R211
COMMENTARY
*Correspondence: p.steendijk@lumc.nl
Department of Cardiology, Leiden University Medical Center, PO Box 9600, 
2300 RC, Leiden, The Netherlands
Steendijk Critical Care 2011, 15:119 
http://ccforum.com/content/15/1/119
© 2011 BioMed Central Ltdisometric twitch force) and prolonged contraction and 
relaxation times with mild hypothermia [11]. Recently, 
studies in isolated failing human myocardium have 
shown very similar results [12]. Despite a prolonged 
action potential, these eﬀ  ects seem not to be associated 
with increased sarcoplasmatic reticulum calcium content 
or altered calcium transients, suggesting that increased 
calcium responsiveness of the myoﬁ  laments is the main 
mechanism for the observed increased inotropism. 
Consistent with these ﬁ  ndings, intact animal studies with 
mild hypothermia have shown increased systolic 
function, resulting in increased cardiac output despite 
reduced heart rate, whereas vascular resistance was 
generally reported to be relatively unaﬀ   ected [11]. In 
contrast, however, in some clinical studies increased 
vascular resistance was reported to dominate and lead to 
a reduced cardiac output [3]. Diﬀ  erences between species 
and anesthesia-analgesia protocols may explain variable 
ﬁ   ndings [13]. Based upon the increased myoﬁ  lament 
calcium sensitivity, impaired diastolic function may 
ensue. Th  is is indeed conﬁ  rmed in a recent study that 
carefully examined the eﬀ   ects of hypothermia on 
diastolic function in an intact pig model showing a 
delayed and prolonged active relaxation and a decreased 
diastolic distensibility. Although the reduced heart rate 
could be expected to compensate and improve diastolic 
ﬁ  lling, this is generally not the case because hypothermia-
induced heart rate reduction results almost entirely from 
a prolonged contraction whereas the diastolic interval is 
virtually unchanged [14].
Th  e complex interplay between intrinsic biophysical 
and biochemical eﬀ  ects and compensatory physiological 
changes combined with potentially altered drug res-
ponses complicates the management of patients sub-
jected to induced hypothermia in the intensive care unit 
[15]. Th  e paper by Filseth and colleagues adds new 
information by reporting on left ventricular function not 
only during induction of hypothermia, but also during 
the re-warming and, particularly, the post-hypothermic 
stage. Th  e ﬁ   ndings during mild hypothermia (34°C) 
largely conﬁ  rm previous reports with improved systolic 
function and depressed diastolic function. However, the 
authors continued cooling to 25°C. During induction of 
severe hypothermia, diastolic function gradually decreased 
further, but systolic function also started to decrease at 
this stage. During re-warming, most indices tended to 
return to baseline values. However, post-hypothermic 
systolic function remained depressed in contrast to 
diastolic function, which fully normalized.
Th   e authors are to be complimented for developing an 
animal model that closely mimics human physiology and 
by using advanced invasive pressure-volume methods to 
assess cardiac function. Th  e main conclusions of the 
paper relate to post-hypothermic circulatory and 
ventricular function. When trying to translate these 
ﬁ  ndings to the clinical situation, several potential limita-
tions of the study should be mentioned. First, the study 
was performed in normal, healthy pigs and the direct 
eﬀ   ects and late consequences of hypothermia may be 
diﬀ  erent in, for example, elderly subjects with depressed 
left ventricular function. Second, the authors induced 
severe hypothermia in contrast to mild hypothermia 
recommended by current guidelines. Th   ird, steady state 
hypothermia was maintained for only 1 hour, which is 
very diﬀ   erent from, for example, the 12 to 24 hours 
recommended for comatose post-cardiac arrest patients. 
Th   us, the study clearly provides interesting new data on 
the eﬀ  ect of temperature on intrinsic ventricular function 
in a clinically relevant animal model. However, the 
translation of the ﬁ  ndings to post-hypothermic critical 
care patients warrants further studies.
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